(CT ± SD) for the TNF-α gene in the drug-naive group (controls) was (25.92 ± 0.5) and in post-OCP treated PCOS group (cases) was (24.88 ± 0.7) (p =  < 0.0001). This evidence concerns the gene TNF and polycystic ovary syndrome.